Previous 10 | Next 10 |
2024-04-30 02:00:03 ET Stan Berenshteyn from Wells Fargo issued a price target of $10.00 for ACCD on 2024-04-30 00:31:00. The adjusted price target was set to $10.00. At the time of the announcement, ACCD was trading at $8.19. The overall price target consensus is at $19...
2024-04-26 17:00:42 ET Gainers: Heartland Financial USA ( HTLF ) +9% . Accolade ( ACCD ) +6% . Editas Medicine ( EDIT ) +4% . Nextracker ( NXT ) +3% . Clean Energy Fuels ( CLNE ) +2% . Losers: Vitru ( VTRU ) -...
2024-04-25 23:29:07 ET Accolade, Inc. (ACCD) Q4 2024 Earnings Conference Call April 25, 2024 16:30 ET Company Participants Todd Friedman - Senior Vice President of Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer ...
2024-04-25 17:31:10 ET Gainers: Alphabet ( GOOGL ) +15% . Alphabet ( GOOG ) +15% . Exponent ( EXPO ) +13% . Columbia Sportswear ( COLM ) +8% . SPS Commerce ( SPSC ) +6% . Losers: Intel Corporation ( INTC )...
2024-04-25 16:15:53 ET More on Accolade Accolade: Staying Bullish On Favorable Developments Progyny slips amid concerns over Alabama fertility ruling Seeking Alpha’s Quant Rating on Accolade Historical earnings data for Accolade Financial infor...
SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024. "Accolade has built a rare healthcare services business at scale with consistently strong growth rates. Whether se...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
2024-04-24 17:20:18 ET More on Accolade Accolade: Staying Bullish On Favorable Developments Progyny slips amid concerns over Alabama fertility ruling Seeking Alpha’s Quant Rating on Accolade Historical earnings data for Accolade Financial infor...
2024-04-09 11:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-05 06:34:44 ET Summary I like Accolade's choice of new partners added year-to-date, as I think the services provided by these partners will be well received by its clients' employees. ACCD's latest "Artificial Intelligence Excellence Award" presented by the Business Intell...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...